GMP BIO CO., LTD.

닫기

For Humans Lives

GMPBIO promises to develop treatments for dementia, depression and diabetes
to contribute to the improvement and welfare the quality of human life.

Nature, Human and Biotechlogy

R&D Biotech company, which specializes in developing new medicines for natural compounds and
research on cell therapy (one of the next-generation growth engines) thinking about the friendly
relationship between human and nature. GMPBIO.

R&D PIPELINE

Natural Product Research & Treg Cell Therapy

  • Alzheimer's disease (Regulatory T Cell)
    GB301. Discovery Close
  • Alzheimer's disease
    GB012. Phase3 Clinical Trial IND ing
  • Chronic obstructive pulmonary disease (COPD)
    GB014. Phase3 Clinical Trial ing
  • Depressive
    GB011. Phase2 Clinical Trial Close
  • Glycemic control
    GB021. Clinical Trial Close
  • Alopecia, Depilation
    GB015. Discovery Close
아래로
R&D 이미지

R&D

Research & Development

Promoting R&D’s advancement by enhancing research capabilities with immune-regulatory cell therapy from natural compounds research.

READ MORE
PIPELINE 이미지

PIPELINE

PIPELINE

Possessing a treatments pipeline of
Dementia, Depression, Diabetes, COPD, etc.

READ MORE
TREG CELL THERAPY 이미지

TREG CELL THERAPY

Why Treg cell?

Immune cell therapy for regulating immune responses, such as inhibition of in-vivo immune responses or improvement of immune responses, and is a major part of the next generation of bio new medicine.

READ MORE

Bio News

top